Abstract：
Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered \'never vaccinated\' and offered a comprehensive course of revaccination. This position statement aims to draw upon the current evidence base and existing guidelines, and align this with national vaccine availability and licensing considerations in order to recommend a pragmatic and standardised re-vaccination schedule for adult and paediatric HSCT recipients in the UK.
摘要：
造血干细胞移植（HSCT）受者对疫苗可预防疾病的适应性免疫力不足。国家和国际指南建议将HSCT接受者视为“从未接种过疫苗”，并提供全面的再接种过程。这份立场声明旨在借鉴目前的证据基础和现有的指导方针，并将其与国家疫苗供应和许可考虑因素保持一致,以便为英国的成人和儿科HSCT接受者推荐实用和标准化的再接种时间表.
